Platelet-Rich Plasma With an Activator: A New Approach for Treating Thin Endometriums of Women Suffering From Infertility

富血小板血浆联合激活剂:治疗不孕症女性子宫内膜过薄的新方法

阅读:1

Abstract

This case study reflects the primary infertility treatment which was in vitro fertilization (IVF) that lasted for four years. This case study involves a 37-year-old female who underwent intrauterine insemination (IUI), recurrent implantation failure, and frozen embryo transfers with a focus on platelet-rich plasma (PRP) for receptor endometrial thickness. The patient's report revealed a hormonal imbalance and a thin endometrium measuring 5 mm, while her husband's semen analysis findings were normal. Activation with calcium chloride PRP therapy successfully helped to achieve an endometrial thickness of 7.1 millimeters, and then, on the second day of the menstrual cycle, gonadotropin-releasing hormone (GnRH) was given. Six oocytes were retrieved, and after intracytoplasmic sperm injection (ICSI), a good-quality blastocyst was developed. On day 21 of the cycle, an embryo of 4AB grade was transferred. Serum beta-human chorionic gonadotropin (β-hCG) was positive, which confirmed pregnancy 14 days after the process of embryo transfer. The patient was advised to take regular check-ups during pregnancy. Recurrent implantation failure and thin endometrium are critical issues in this case, demonstrating that PRP can be used to augment the endometrial thickness to improve the pregnancy rate.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。